RS-17053 (N-[2-(2-cyclopropylmethoxyphenoxy)ethyl]-5-chloro-alpha, alpha-dimethyl-1H-indole-3-ethanamine hydrochloride), a selective alpha 1A-adrenoceptor antagonist, displays low affinity for functional alpha 1-adrenoceptors in human prostate: implications for adrenoceptor classification

AP Ford, NF Arredondo, DR Blue , DW Bonhaus, J Jasper, MS Kava, J Lesnick, JR Pfister, IA Shieh, RL Vimont, TJ Williams, JE McNeal, TA Stamey and DE Clarke

Center for Neurobiology, Roche Bioscience, Palo Alto, California, USA.

Norepinephrine (NE) contracts smooth muscle cells within the human lower urinary tract (LUT) (bladder neck, prostate, and urethra). Receptor distribution and pharmacological evidence have implicated activation of alpha 1A-adrenoceptors. We disclose the pharmacological properties of the novel, selective alpha 1A-adrenoceptor antagonist N- [2-(2-cyclopropylmethoxyphenoxy)ethyl]-5-chloro- alpha,alpha-dimethyl- 1H-indole-3-ethanamine hydrochloride (RS-17053) and examine critically the pharmacological identity of the alpha 1-adrenoceptor mediating contractions to NE in human LUT tissues. In several tissues from rat and cloned adrenoceptors, RS-17053 displayed high affinity for the alpha 1A-adrenoceptor (pKi and pA2 estimates of 9.1-9.9) and a 30-100- fold selectivity over the alpha 1B- and the alpha 1D-adrenoceptor subtypes (pK1 and pA2 estimates of 7.7-7.8). However, in isolated smooth muscle preparations from human LUT tissues, RS-17053 antagonized responses to NE only at high concentrations. Estimates of affinity (pA2) at alpha 1-adrenoceptors mediating NE-induced contractions were 7.5 in prostatic periurethral longitudinal smooth muscle (compared with 8.6 for prazosin), 6.9 in anterior fibromuscular stroma (prazosin, 8.9), and 7.1 in bladder neck (prazosin, 8.5). These findings indicate that contractile responses to NE in human LUT tissues are mediated by a receptor displaying pharmacological properties that are clearly different from those of the defined alpha 1A-adrenoceptor and raise the possibility that multiple forms of the alpha 1A-adrenoceptor may exist in human LUT that are discriminated by RS-17053. In this regard, the affinity estimates obtained with RS-17053 and other alpha 1- adrenoceptor antagonists in human LUT tissues are identical to those described for the putative alpha 1L-adrenoceptor.

Volume 49, Issue 2, pp. 209-215, 02/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				M. T.C.C. Patrao, D. B.C. Queiroz, G. Grossman, P. Petrusz, M. d. F. M. Lazari, and M. C. W. Avellar Cloning, expression and immunolocalization of {alpha}1-adrenoceptor in different tissues from rhesus monkey and human male reproductive tract Mol. Hum. Reprod., February 1, 2008; 14(2): 85 - 96. [Abstract] [Full Text] [PDF]

				X. Chen, S. F. Perry, S. Aris-Brosou, C. Selva, and T. W. Moon Characterization and functional divergence of the {alpha}1-adrenoceptor gene family: insights from rainbow trout (Oncorhynchus mykiss) Physiol Genomics, December 19, 2007; 32(1): 142 - 153. [Abstract] [Full Text] [PDF]

				X. Chen, T. W. Moon, K. R. Olson, R. A. Dombkowski, and S. F. Perry The effects of salt-induced hypertension on {alpha}1-adrenoreceptor expression and cardiovascular physiology in the rainbow trout (Oncorhynchus mykiss) Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1384 - R1392. [Abstract] [Full Text] [PDF]

				D. Marti, R. Miquel, K. Ziani, R. Gisbert, M. D. Ivorra, E. Anselmi, L. Moreno, V. Villagrasa, D. Barettino, and P. D'Ocon Correlation between mRNA levels and functional role of {alpha}1-adrenoceptor subtypes in arteries: evidence of {alpha}1L as a functional isoform of the {alpha}1A-adrenoceptor Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H1923 - H1932. [Abstract] [Full Text] [PDF]

				Y. Hiraizumi-Hiraoka, T. Tanaka, H. Yamamoto, F. Suzuki, and I. Muramatsu Identification of {alpha}-1L Adrenoceptor in Rabbit Ear Artery J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 995 - 1002. [Abstract] [Full Text] [PDF]

				M. A. Uberti, R. A. Hall, and K. P. Minneman Subtype-Specific Dimerization of {alpha}1-Adrenoceptors: Effects on Receptor Expression and Pharmacological Properties Mol. Pharmacol., December 1, 2003; 64(6): 1379 - 1390. [Abstract] [Full Text] [PDF]

				A. A. Hancock, S. A. Buckner, M. E. Brune, T. A. Esbenshade, L. M. Ireland, S. Katwala, I. Milicic, M. D. Meyer, J. F. Kerwin Jr., and M. Williams Preclinical Pharmacology of Fiduxosin, a Novel alpha 1-Adrenoceptor Antagonist with Uroselective Properties J. Pharmacol. Exp. Ther., February 1, 2002; 300(2): 478 - 486. [Abstract] [Full Text] [PDF]

				M. E. Brune, S. P. Katwala, I. Milicic, D. G. Witte, J. F. Kerwin Jr., M. D. Meyer, A. A. Hancock, and M. Williams Effect of Fiduxosin, an Antagonist Selective for alpha 1A- and alpha 1D-Adrenoceptors, on Intraurethral and Arterial Pressure Responses in Conscious Dogs J. Pharmacol. Exp. Ther., February 1, 2002; 300(2): 487 - 494. [Abstract] [Full Text] [PDF]

				D. B.C. Queiroz, F. R. Mendes, C. S. Porto, and M. C. W. Avellar {alpha}1-Adrenoceptor Subtypes in Rat Epididymis and the Effects of Sexual Maturation Biol Reprod, February 1, 2002; 66(2): 508 - 515. [Abstract] [Full Text] [PDF]

				Y. P. R. Jarajapu, F. Johnston, C. Berry, A. Renwick, J. C. McGrath, A. MacDonald, and C. Hillier Functional Characterization of alpha 1-Adrenoceptor Subtypes in Human Subcutaneous Resistance Arteries J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 729 - 734. [Abstract] [Full Text] [PDF]

				M. Salomonsson, M. Oker, S. Kim, H. Zhang, J. E. Faber, and W. J. Arendshorst {alpha}1-Adrenoceptor subtypes on rat afferent arterioles assessed by radioligand binding and RT-PCR Am J Physiol Renal Physiol, July 1, 2001; 281(1): F172 - F178. [Abstract] [Full Text] [PDF]

				S. Guimaraes and D. Moura Vascular Adrenoceptors: An Update Pharmacol. Rev., June 1, 2001; 53(2): 319 - 356. [Abstract] [Full Text] [PDF]

				S. Yamada, T. Okura, and R. Kimura In Vivo Demonstration of {alpha}1A-Adrenoceptor Subtype Selectivity of KMD-3213 in Rat Tissues J. Pharmacol. Exp. Ther., January 1, 2001; 296(1): 160 - 167. [Abstract] [Full Text]

				S. A. Argyle and J. C. McGrath An alpha 1A/alpha 1L-Adrenoceptor Mediates Contraction of Canine Subcutaneous Resistance Arteries J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 627 - 633. [Abstract] [Full Text]

				J. F. Mackenzie, C. J. Daly, J. D. Pediani, and J. C. McGrath Quantitative Imaging in Live Human Cells Reveals Intracellular alpha 1-Adrenoceptor Ligand-Binding Sites J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 434 - 443. [Abstract] [Full Text]

				K. Akiyama, M. Hora, S. Tatemichi, N. Masuda, S. Nakamura, R. Yamagishi, and M. Kitazawa KMD-3213, a Uroselective and Long-Acting alpha 1a-Adrenoceptor Antagonist, Tested in a Novel Rat Model J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 81 - 91. [Abstract] [Full Text]

				S. Yamada, T. Ohkura, Y. Deguchi, and R. Kimura In Vivo Measurement by [3H]Tamsulosin of alpha 1 Adrenoceptors in Rat Tissues in Relation to the Pharmacokinetics J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1575 - 1583. [Abstract] [Full Text]

				J.-M. Ye and E. Q. Colquhoun Changes in Functional Expression of Alpha-1 Adrenoceptors in Hindlimb Vascular Bed of Spontaneously Hypertensive Rats and their Effects on Oxygen Consumption J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 599 - 606. [Abstract] [Full Text]

				A. M. Low, H. Lu-Chao, Y. F. Wang, R. D. Brown, C. Y. Kwan, and E. E. Daniel Pharmacological and Immunocytochemical Characterization of Subtypes of Alpha-1 Adrenoceptors in Dog Aorta J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 894 - 901. [Abstract] [Full Text]

				A. Leonardi, J. P. Hieble, L. Guarneri, D. P. Naselsky, E. Poggesi, G. Sironi, A. C. Sulpizio, and R. Testa J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1272 - 1283. [Abstract] [Full Text]

				R. Testa, L. Guarneri, P. Angelico, E. Poggesi, C. Taddei, G. Sironi, D. Colombo, A. C. Sulpizio, D. P. Naselsky, J. P. Hieble, et al. J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1284 - 1293. [Abstract] [Full Text]

				X. Xin, N. Yang, A. D. Eckhart, and J. E. Faber alpha 1D-Adrenergic Receptors and Mitogen-Activated Protein Kinase Mediate Increased Protein Synthesis by Arterial Smooth Muscle Mol. Pharmacol., May 1, 1997; 51(5): 764 - 775. [Abstract] [Full Text]